Form 4: Third Harmonic Bio CEO Natalie Holles Executes Stock Option and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Third Harmonic Bio CEO Natalie Holles exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On April 11, 2024, Natalie Holles, CEO of Third Harmonic Bio, Inc., exercised stock options to acquire 13,558 shares of common stock at a price of $4.20 per share.
  • Simultaneously, Holles sold 13,558 shares of common stock at a weighted average price of $12.1857 per share, with individual sales ranging from $12.15 to $12.31.
  • These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted in [Month XX, 2023].
  • Following these transactions, Holles directly owns 1,218,836 shares of Third Harmonic Bio, Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

The filing reflects routine transactions by a company executive under a pre-arranged trading plan, which is a common practice to avoid accusations of insider trading. It provides transparency into executive compensation and stock ownership.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership structure.
  • The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
March 27, 2024Date of Limited Power of Attorney execution.
April 11, 2024Date of stock option exercise and share sale.
April 15, 2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.